3Dong Y, Wang BC, Zhang YX. Clinical and experimental study on treatment of infantile mycotic enteritis by jiechang mixture. Zhongguo Zhongxiyijiehe Zazhi 2001; 21:419-421.
4van Burik JA, Magee PT. Aspects of fungal pathogenesis in humans. Annu Rev Microbiol 2001;55:743-772.
5Hawser S, Islam K. Comparisons of the effects of fungicidal and fungistatic antifungal agents on the morphogenetic transformation of Candida albicans. J Antimicrob Chemother 1999; 43:411-413.
6Cheng HR, Jiang N. Extremely rapid extraction of DNA from bacteria and yeasts. Biotechnol Lett 2006;28:55-59.
7Suzuki K, Sasaki J, Uramoto M, Nakase T, Komagata K, Agromyces mediolanus sp. nov., nom, rev,, comb. nov,, a species for "Corynebacterium mediolanum" Mamoli 1939 and for some aniline-assimilating bacteria which contain 2, 4-diaminobutyric acid in the cell wall peptidoglycan. Int J Syst Bacteriol 1996; 46:88-93.
8Abe S, Satoh T, Tokuda Y, Tansho S, Yamaguchi H. A rapid colorimetric assay for determination of leukocyte-mediated inhibition of mycelial growth of Candida albicans, Microbiol Immunol 1994; 38:385-388.
9Noverr MC, Huffnagle GB, Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect Immun 2004; 72:6206-6210.
10Atanassova M, Choiset Y, Dalgalarrondo M, Chobert JM, Dousset X, Ivanova I, Haertle T. Isolation and partial biochemical characterization of a proteinaceous anti-bacteria and anti-yeast compound produced by Lactobacillus paracasei subsp, paracasei strain M3. Int J Food Microbiol 2003;87:63-73.
